Skip to main content

Advertisement

Log in

Automated monitoring of symptoms during ambulatory chemotherapy and oncology providers’ use of the information: a randomized controlled clinical trial

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Monitoring patient-reported symptoms is necessary to adjust and improve supportive care during chemotherapy. Continuing advances in computerized approaches to symptom monitoring can enhance communication about unrelieved symptoms between patients and oncology providers and may facilitate intensified symptom treatment.

Methods

An automated IT-based telephone monitoring system was developed to enable oncology providers to receive and act on alert reports from patients about unrelieved symptoms during chemotherapy treatment. Daily, 250 participants (randomized to treatment or attentional control) were asked to call the automated system to report presence, severity, and distress for common chemotherapy-related symptoms (1–10 scale if present). For the treatment group, symptoms exceeding preset thresholds for moderate-to-severe intensity levels generated emailed alert reports to both the patient’s oncologist and oncology nurse.

Results

Patients reported high satisfaction and ease of use of the automated system. Over 80 % of providers reported usefulness of the symptom alert reports. Ten monitored symptoms resulted in, on average, nine moderate-to-severe intensity alerts per patient over 45 study days. However, providers rarely contacted patients after receiving alerts. There were no significant differences in change of symptom severity between the two groups (mean difference = 0.06, p = 0.58).

Conclusion

Despite patients’ use of a daily symptom monitoring system and providers’ receipt of information about unrelieved symptoms of moderate-to-severe intensity, oncology physicians and nurses did not contact patients to intensify symptom treatment nor did symptoms improve. Further research is indicated to determine if oncology providers initiated follow-up to intensify symptom treatment, whether symptom outcomes would improve.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Atherton P, Sloan J (2006) Rising importance of patient-reported outcomes. Lancet Oncol 7(11):883–884

    Article  PubMed  Google Scholar 

  2. Basch E, Abernethy A (2011) Supporting clinical practice decisions with real-time patient-reported outcomes. J Clin Oncol 29(8):954–956

    Article  PubMed  Google Scholar 

  3. Bren L (2006) The importance of patient-reported outcomes. It’s all about the patients. FDA Consum 40(6):26–33

    PubMed  Google Scholar 

  4. Grenhalgh J (2009) The applications of PROs in clinical practice: what are they, do they work, and why? Qual Life Res 18(1):115–123

    Article  Google Scholar 

  5. Trotti A et al (2007) Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol 25(32):5121–5127

    Article  PubMed  Google Scholar 

  6. Wu A et al (2012) Adding the patient perspective to comparative effectiveness research. Health Aff 29(10):1863–1871

    Article  Google Scholar 

  7. Carpenter JS et al (2008) Oncology outpatient and provider responses to a computerized symptom assessment system. Oncol Nurs Forum 35(4):661–669

    Article  PubMed Central  PubMed  Google Scholar 

  8. Given C et al (2008) Managing symptoms among patients with breast cancer during chemotherapy: results of a two-arm behavioral trial. J Clin Oncol 26:5855–5862

    Article  PubMed Central  PubMed  Google Scholar 

  9. Basch E et al (2005) Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol 23(15):3552–3561

    Article  PubMed  Google Scholar 

  10. Basch E et al (2005) Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol: Off J Am Soc Clin Oncol 23(15):3552–3561

    Article  Google Scholar 

  11. Berry D et al (2011) Enhancing patient–provider communication with the electronic self-report assessment for cancer: a randomized trial. J Clin Oncol 29(8):1029–1035

    Article  PubMed Central  PubMed  Google Scholar 

  12. Mark T, Fortner B, Johnson G (2008) Evaluation of a tablet PC technology to screen and educate oncology patients. Support Care Cancer 16(4):371–378

    Article  PubMed  Google Scholar 

  13. Finkelstein J, Friedman R (2000) The potential role of telecommunications technologies in the management of chronic health conditions. Dis Manag Health Outcomes 8(2):57–63

    Article  Google Scholar 

  14. Main D et al (2005) A qualitative study of work and work return in cancer survivors. Psychooncology 14(11):992–1004

    Article  PubMed  Google Scholar 

  15. Mooney KH et al (2002) Telephone-linked care for cancer symptom monitoring: a pilot study. Cancer Pract 10(3):147–154

    Article  PubMed  Google Scholar 

  16. Cleeland C et al (2011) Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol 29(8):994–1000

    Article  PubMed Central  PubMed  Google Scholar 

  17. Kobak KA et al (1996) Computer-administered clinical rating scales. A review. Psychopharmacology (Berl) 127(4):291–301

    Article  CAS  Google Scholar 

  18. Hilarius D et al (2008) Use of health-related quality-of-life assessments in daily clinical oncology nursing practice: a community hospital-based intervention study. Cancer 113(3):628–637

    Article  PubMed  Google Scholar 

  19. Velikova G et al (2004) Measuring quality of life in routine oncology practice improves communication and patient well-being:a randomized controlled trial. J Clin Oncol 22(4):714–724

    Article  PubMed  Google Scholar 

  20. Williams E et al (2012) Randomised controlled trial of an automated, interactive telephone intervention (TLC Diabetes) to improve type 2 diabetes management: baseline findings and six-month outcomes. BMC Public Health 12:602–612

    Article  PubMed Central  PubMed  Google Scholar 

  21. Salminen E et al (2008) Needs of developing the skills of palliative care at the oncology ward: an audit of symptoms among 203 consecutive cancer patients in Finland. Support Care Cancer 16(1):3–8

    Article  CAS  PubMed  Google Scholar 

  22. Teunissen SC et al (2007) Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manag 34(1):94–104

    Article  Google Scholar 

  23. Cleeland C, Mendoza T (2011) Symptom measurement by patient report. In: Cleeland C, Fisch M, Dunn A (eds) Cancer symptom science: measurement, mechanisms and management. Cambridge University Press, Cambridge, pp 271–289

    Google Scholar 

  24. Stewart BJ, Archbold PG (1993) Nursing intervention studies require outcome measures that are sensitive to change part 2. Res Nurs Health 16(1):77–81

    Article  CAS  PubMed  Google Scholar 

  25. Youngblut JM, Caspar GR (1993) Single item indicators in nursing research. Res Nurs Health 16:459–465

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This research was funded by the National Institutes of Health, National Cancer Institute (R01 CA89474). The content is solely the responsibility of the authors.

Conflict of interest

The authors have no financial relationship with the National Cancer Institute other than they had salary and benefit support during the implementation of the study. Study funding is now complete. The first three authors have full control of all primary data and agree to allow the journal to review pertinent de-identified data if requested.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kathi H. Mooney.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mooney, K.H., Beck, S.L., Friedman, R.H. et al. Automated monitoring of symptoms during ambulatory chemotherapy and oncology providers’ use of the information: a randomized controlled clinical trial. Support Care Cancer 22, 2343–2350 (2014). https://doi.org/10.1007/s00520-014-2216-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-014-2216-1

Keywords

Navigation